• Return to Headlines

Emergent Biosolu Shares Up 11.7% Since SmarTrend's Buy Recommendation (EBS)

By Amy Schwartz

SmarTrend identified an Uptrend for Emergent Biosolu (NYSE:EBS) on January 10th, 2020 at $56.82. In approximately 1 month, Emergent Biosolu has returned 11.73% as of today's recent price of $63.48.

Emergent Biosolu share prices have moved between a 52-week high of $67.45 and a 52-week low of $39.11 and are now trading 62% above that low price at $63.48 per share. The 200-day and 50-day moving averages have moved 0.38% higher and 1.18% higher over the past week, respectively.

Emergent BioSolutions, Inc. is a global specialty biopharmaceutical company. The Company develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. Emergent also develops and commercializes therapeutics and other specialty products for hospitals and clinics.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Emergent Biosolu shares.

Log in and add Emergent Biosolu (EBS) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights emergent biosolu

Ticker(s): EBS